Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Clinical Trial of Exablate for Low Intensity Focused Ultrasound Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Abuse Disorders (SUDs)

NCT04197921 is registered in ClinicalTrials.gov with InSightec as lead sponsor.

NCT NCT04197921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04197921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Clinical Trial of Exablate for Low Intensity Focused Ultrasound Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Abuse Disorders (SUDs)
Lead sponsor
InSightec
Phase
Not applicable
Overall status
Recruiting
Start date
November 27, 2019
Completion date
December 31, 2027
Enrollment
29 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

opioid-use disorder, substance use disorders